宝利化制药的这项研究成功发表，不仅为公司推动CNS数字药的落地奠定了科研基础，也为公司的数字药研发平台揭开了新篇章。未来，宝利化制药将继续以科技创新与数字研发为驱动力，致力于用科技创新打造数智制药企业领军者，为人类的健康事业贡献力量。

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.

Voyager Therapeutics leverages its TRACER platform for targeted gene therapies, focusing on challenging CNS diseases like ...